European Neuropsychopharmacology
- Psychedelics and suicidality: A double-edged sword – risks, mechanisms, and moving forward4 days ago
- Editorial Board1 week ago
- Social cognitive impairment across the bipolar disorder continuum: A comparative study of high-risk, first-episode, and chronic groups2 weeks ago
- EEG resting-state gamma power as a potential biomarker of excitation / inhibition imbalance in autism: Evidence from the Autism Biomarkers Consortium for Clinical Trials2 weeks ago
- Prevalence and correlates of problematic social media use in Chinese adolescent psychiatric patients in Hong Kong2 weeks ago
- Viewing reproductive psychiatry through a three-patient framework2 weeks ago
- Genetic architecture of externalizing and internalizing traits in the general population and its link to psychiatric conditions and well-being: a multivariate approach3 weeks ago
- Long-term outcomes of childhood ADHD stimulant use trajectories3 weeks ago
- Erratum to “Long-term treatment with esketamine nasal spray in patients with treatment resistant depression: Results from the ESCAPE-LTE study” [European Neuropsychopharmacology 107 (2026) 112801]4 weeks ago
- Global patterns of clozapine prescribing: An international comparison of prescribing indications across 15 regions1 month ago
- Cognitive reserve beyond ageing and dementia: A framework for early psychosis prevention and intervention1 month ago
- Corrigendum to “T70. Genetics of treatment resistant depression in Pakistan; update from the DIVERGE study” [European Neuropsychopharmacology 87, Supplement 1 (2024) 191]2 months ago
- The impact of anhedonia on physical health and somatic diseases: an exploratory literature review2 months ago
- Clinical guidance on the use of esketamine nasal spray for patients with treatment resistant depression: A European Delphi consensus report2 months ago
- Emerging pharmacological and neuromodulation interventions for suicidal ideation and behaviour2 months ago
- The multivariate genetic architecture of psychiatric and insulin resistance multimorbidity2 months ago
- Commentary on: The American Society of Clinical Psychopharmacology task force consensus statement on the deprescribing of stimulant medications in adults with ADHD3 months ago
- Genomic relationship between polyendocrine metabolic ovarian syndrome and bipolar disorder3 months ago
- Corrigendum to “Functioning assessment short test for autism (FAST-A): a tool to evaluate adaptive functioning in autistic adults” [European Neuropsychopharmacology, 112, 112887]3 months ago
- Genetic overlap between depression and C-reactive protein levels: Evidence from a cross-trait analysis3 months ago
- Variability in AI-generated psychedelic definitions across major chatbots3 months ago
- In-patient treatment and structural dysconnectivity in major depression – A longitudinal connectome study3 months ago
- Neuroimaging predictors of cognitive benefits after virtual reality-based cognitive remediation in mood or schizophrenia spectrum disorders3 months ago
- Childhood maltreatment is linked to transdiagnostic age- and sex-specific cortical thinning and reduced amygdalar volume in young adults3 months ago
- Response to: Commentary on “Long-term treatment with esketamine nasal spray in patients with treatment resistant depression: Results from the ESCAPE-LTE study”4 months ago
- Functioning assessment short test for autism (FAST-A): a tool to evaluate adaptive functioning in autistic adults4 months ago
- Recommendations of the ECNP Digital Network for the evaluation of mental health care apps: A Delphi consensus4 months ago
- Dot the i’s and cross the t’s: Can we get resilience in bipolar disorder right, please?4 months ago
- Reconsidering regression-based predictors in adults with attention‑deficit/hyperactivity disorder and substance use disorders4 months ago
- Prevalence and outcomes of co-occurring psychiatric and endocrine, metabolic, and nutritional disorders: An atlas based on umbrella review of 254,154,533 records4 months ago
- From association to screening: calibrating neurological risk in severe mental illness4 months ago
- Blinding integrity in psychedelic research: Evidence from a comparative randomized controlled trial of psilocybin, MDMA, and methylphenidate in healthy volunteers4 months ago
- Rethinking neurocognitive and cardiometabolic screening in severe mental illness4 months ago
- The American Society of Clinical Psychopharmacology task force consensus statement on the deprescribing of stimulant medications in adults with ADHD✰4 months ago
- Response to Ma et al.4 months ago
- Psychomotor slowing as a predictor of treatment outcomes in major depressive disorder with acute suicidality: Insights from the OASIS-D study4 months ago
- Antidepressant use and colorectal cancer risk: A systematic review and meta-analysis of epidemiological studies4 months ago
- The genetic architecture of autistic traits and negative symptoms in non-affective first-episode psychosis: an exploratory longitudinal study4 months ago
- Reclassifying dropouts from antipsychotic trials due to study-reported adverse events: a systematic review and individual-participant-data meta-analyses4 months ago
- Risk of self-harm in first-diagnosed mental disorders: A 16-year territory-wide health-record database study in Hong Kong4 months ago
- Population-based prevalence and pharmacotherapy sequences of treatment resistant depression in Germany4 months ago
- Antidepressant use and risk of bipolar disorder in children, adolescents and young adults with unipolar depression: a target trial emulation study5 months ago
- Brain signatures of childhood trauma and polygenic scores for mental health drive clinical subtypes in depression: a UK Biobank study5 months ago
- Letter to the editor: Comment on Kozyr et al. (2026) “Complexity or simplicity? A replication analysis of low heart rate as a predictor of TMS response in major depressive disorder”5 months ago
- Response letter to Hu et al.: “Methodological points for consideration: Enhancing the interpretation of the COH-FIT findings”5 months ago
- Effectiveness of GLP-1RA vs metformin for diabetes prevention in antipsychotic-treated patients5 months ago
- A misleading moniker: Why bipolar II disorder deserves a new name?5 months ago
- When clinical trials fail to represent patients: implications for schizophrenia guidelines5 months ago
- The double-edged prescription: Maternal medications and fetal brain vulnerability5 months ago
- Real-world use of xanomeline/trospium chloride in a large academic healthcare system in the first year following FDA approval5 months ago
- Social dysfunction and default mode network functional integrity in neuropsychiatric disorders: A cross-disorder replication and generalization study5 months ago
- A call for the systematic assessment of sexual adverse events in ketamine and esketamine trials and clinical practice5 months ago
- Lithium response in families can inform the selection of long-term treatment of bipolar disorder5 months ago
- Age-stratified associations between severe mental illness, dementia, and ischemic stroke: findings from the PADRIS-PRESTO cohort5 months ago
- Perinatal bipolar disorder as a critical risk window: rationale for hospitalization at home on this population5 months ago
- Pathway-selective signaling of serotonergic psychedelics at 5-HT receptors: Implications for psychoactivity, safety, and therapeutic potential5 months ago
- Shared and distinct effects of mood stabilizers on epigenetic machinery gene expression: an exploratory study in HeLa cells6 months ago
- Response to “Gene-environment interactions and white matter integrity in mood disorders: Further directions”6 months ago
- Dissecting the pleiotropic genetic architecture of suicide attempt, suicidal ideation, and thirteen correlated traits6 months ago
- Structural brain findings associated with clinical profiles but not diagnosis in unmedicated adults with obsessive-compulsive disorder: the Global OCD study6 months ago
- Sexual dysfunction in bipolar disorder: A systematic review6 months ago
- Relapse and its modifiers after antipsychotic discontinuation in first-episode non-affective psychosis: A systematic review and meta-analysis6 months ago
- Selective reinforcement learning deficits in antipsychotic-naïve patients with first-episode schizophrenia-spectrum disorder6 months ago
- Prevalence and outcomes of co-occurring psychiatric and neurological disorders: An atlas based on umbrella review of 81 meta-analyses6 months ago
- Cognitive phenotypes in early psychiatric illness: Stability, resilience, and the path to precision medicine6 months ago
- Long-term adjunctive lumateperone 42 mg treatment in major depressive disorder: Results from a 6-month open-label extension study6 months ago
- Dissecting the shared genetic architecture of ADHD and substance use disorders: Promising leads and persistent challenges6 months ago
- Revisiting the earlier, pre-CHR-P prodrome of psychotic illness: a desideratum for advancing early intervention?6 months ago
- Treatment of bipolar depression: results from a comprehensive network meta-analysis and updated systematic review6 months ago
- Commentary on “Long-term treatment with esketamine nasal spray in patients with treatment resistant depression: Results from the ESCAPE-LTE study”6 months ago
- Adopting a “dual-track” inclusion strategy aligned with DSM-5 clinical diagnosis to enhance the clinical translatability of study findings6 months ago
- Efficacy of 3,4-methylenedioxymethamphetamine (MDMA)-assisted therapy for posttraumatic stress disorder: A systematic review and meta-analysis of clinical and functional outcomes6 months ago
- Evidence of phenotypes indexing cognitive resilience and vulnerability in the early course of mood and psychosis spectrum illness; mapping the latent structure, characteristics, and longitudinal stability of cognitive heterogeneity7 months ago
- Is the time ripe for psychiatry to adopt a “mental health engineering” lens?7 months ago
- Involuntary movements integral to psychotic illness: a ‘circular epistemological journey’ informing the pathobiology and treatment of psychosis and reconceptualising tardive dyskinesia7 months ago
- Critical considerations on the trial of FAAH inhibitor JNJ-42165279 in major depressive disorder with anxious distress7 months ago
- Unraveling the genetic architecture of depression-atherosclerosis comorbidity: a paradigm shift in understanding mind-heart connections7 months ago
- Methodological points for consideration: Enhancing the interpretation of the COH-FIT findings7 months ago
- Long-term treatment with esketamine nasal spray in patients with treatment resistant depression: Results from the ESCAPE-LTE study7 months ago
- Polygenic risk scores reveal genetic underpinnings of comorbidity betweensubstance use disorders and ADHD7 months ago
- The antioxidant paradox in pregnancy7 months ago
- Complexity or simplicity? A replication analysis of low heart rate as a predictor of TMS response in major depressive disorder7 months ago
- Editorial Board7 months ago
- Strategies for enhancing methodological rigor and clinical relevance of eating disorders-schizophrenia spectrum disorders risk association studies7 months ago
- Personality, not cognition, distinguishes chronic ayahuasca and cannabis users from non-users7 months ago
- Updating clozapine prescribing guidelines in Italy: a step forward modernity7 months ago
- Predictors of treatment success in patients with substance use disorder (SUD) and co-morbid attention deficit/hyperactivity disorder (ADHD): Results from the International Naturalistic Cohort Study of ADHD and SUD (INCAS)8 months ago
- Comment on “All-cause and cause-specific mortality in people with mental disorders: a population-based study on risk evaluation, effect modifiers and excess life-years lost in Hong Kong”8 months ago
- Major depression and atherosclerotic disease: Linking shared genetics to pathways in blood, brain, heart, and atherosclerotic plaques8 months ago
- Efficacy and safety of adjunctive treatment with the fatty acid amide hydrolase inhibitor JNJ-42165279 in participants with major depressive disorder with anxious distress: A double-blind, placebo-controlled, randomised study8 months ago
- Emerging neurobiological targets in psychiatric treatment8 months ago
- Traumatic loss, bereavement, and prolonged grief disorder in times of war: insights from Ukraine8 months ago
- Esketamine in bipolar depression: Unreproducible data8 months ago
- Response to the letter regarding “risk of manic switch and suicidal outcomes in bipolar depression treated with esketamine”8 months ago
- Antipsychotic plasma concentration as predictor of movement disorders and cardiometabolic side-effects: A comparison with prescription dose8 months ago
- Gene-environment interactions and white matter integrity in mood disorders: Further directions8 months ago
- Child and maternal hair oxytocin: A novel biomarker of dyadic emotional availability8 months ago
- Bridging the reporting gap: Application of the ReSPCT guidelines in psilocybin clinical trial protocols8 months ago
- Response to the letter regarding “Default mode network integrity across neuropsychiatric disorders and its relation to social dysfunction: A normative modelling approach”8 months ago
- Biomarker innovations in precision psychiatry diagnostics and treatment strategies8 months ago